journal article·2023-04

Electricity‐Wettability Controlled Fast Transmission of Dopamine in Nanochannels

Yuan Fang, Weiwei Xu, Lei Yang, Haonan Qu, Wenqian Wang, Siyun Zhang, Haibing Li

Small· Volume 19· Issue 15
Publisher page

Abstract

Abstract Achieving fast transmembrane transmission of molecules in organisms is a challenging problem. Inspired by the transport of Dopmine (DA) in organisms, the DA transporter (DAT) binds to DA in a way that has a ring recognition (the recognition group is the tryptophan group). Herein, D‐Tryptophan‐pillar[5]arene (D‐Trp‐P5) functionalized conical nanochannel is constructed to achieve fast transmission of DA. The D‐Trp‐P5 functionalized nanochannel enables specific wettability recognition of DA molecules and has great cycle stability. With the controlling of voltage to wettability, the transport flux of DA is up to 499.73 nmol cm−2 h−1 at −6 V, 16.88 times higher than that under positive voltages. In response to these results, a high‐throughput DA transport device based on controlled electricity‐wettability is provided.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanopore and Nanochannel Transport Studies · Microfluidic and Capillary Electrophoresis Applications · Covalent Organic Framework Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Key Laboratory of Green Pesticide College of Chemistry Central China Normal University Wuhan 430079 P. R. China

Funding

National Basic Research Program of China · National Natural Science Foundation of China

References (73)

Show source-provided references
1. 10.1007/s00425005009610.1007/s004250050096 ↗
2. 10.1038/ncomms874710.1038/ncomms8747 ↗
3. 10.1021/acsami.7b1035910.1021/acsami.7b10359 ↗
4. 10.1038/s41467-017-02088-w10.1038/s41467-017-02088-w ↗
5. 10.1246/cl.18028810.1246/cl.180288 ↗
6. 10.1038/ncomms1415210.1038/ncomms14152 ↗
7. 10.1002/smll.20170194210.1002/smll.201701942 ↗
8. 10.1038/nature1341910.1038/nature13419 ↗
9. 10.1021/acs.chemmater.5b0385910.1021/acs.chemmater.5b03859 ↗
10. 10.1038/3503651910.1038/35036519 ↗
11. 10.1038/ncomms537710.1038/ncomms5377 ↗
12. 10.1016/j.jmb.2014.07.03010.1016/j.jmb.2014.07.030 ↗
13. 10.1021/acsnano.6b0786510.1021/acsnano.6b07865 ↗
14. 10.1529/biophysj.105.08043210.1529/biophysj.105.080432 ↗
15. 10.1126/science.291.5504.63310.1126/science.291.5504.633 ↗
16. 10.1126/science.107599710.1126/science.1075997 ↗
17. 10.1007/s10571-018-0632-310.1007/s10571-018-0632-3 ↗
18. 10.3389/fnagi.2014.0025210.3389/fnagi.2014.00252 ↗
19. 10.1038/s41586-019-1235-y10.1038/s41586-019-1235-y ↗
20. 10.1021/acschemneuro.6b0039510.1021/acschemneuro.6b00395 ↗
21. 10.1038/nrneurol.2015.17210.1038/nrneurol.2015.172 ↗
22. 10.1016/j.nbd.2018.11.00110.1016/j.nbd.2018.11.001 ↗
23. 10.3390/cells902026010.3390/cells9020260 ↗
24. 10.1038/nature1253310.1038/nature12533 ↗
25. 10.2174/18715270678411157910.2174/187152706784111579 ↗
26. Aggarwal S. · Curr. Protoc. Pharmacol. · 2017 · 79
27. 10.1039/c0cs00053a10.1039/c0cs00053a ↗
28. 10.1016/S0168-583X(03)00884-X10.1016/S0168-583X(03)00884-X ↗
29. 10.1021/acsnano.1c0858210.1021/acsnano.1c08582 ↗
30. 10.1016/j.nantod.2015.11.00110.1016/j.nantod.2015.11.001 ↗
31. 10.1016/j.electacta.2016.08.06710.1016/j.electacta.2016.08.067 ↗
32. 10.1021/ac102795a10.1021/ac102795a ↗
33. 10.1039/C4TA05013D10.1039/C4TA05013D ↗
34. 10.1021/acsami.7b1450510.1021/acsami.7b14505 ↗
35. 10.1038/s41467-019-09163-410.1038/s41467-019-09163-4 ↗
36. 10.1039/c2cc17277a10.1039/c2cc17277a ↗
37. 10.1021/acsnano.6b0872710.1021/acsnano.6b08727 ↗
38. 10.1002/chem.20130052810.1002/chem.201300528 ↗
39. 10.1002/adma.20140556410.1002/adma.201405564 ↗
40. 10.1039/C6CC03943J10.1039/C6CC03943J ↗
41. 10.1002/smll.20140065810.1002/smll.201400658 ↗
42. 10.1021/acsami.9b1308810.1021/acsami.9b13088 ↗
43. 10.1021/am500282210.1021/am5002822 ↗
44. 10.1021/acsami.8b0568610.1021/acsami.8b05686 ↗
45. 10.1039/C5SC04726A10.1039/C5SC04726A ↗
46. 10.1021/acs.nanolett.1c0105510.1021/acs.nanolett.1c01055 ↗
47. 10.1039/C9CC06615B10.1039/C9CC06615B ↗
48. 10.1002/anie.20201298410.1002/anie.202012984 ↗
49. 10.1021/acs.analchem.6b0268210.1021/acs.analchem.6b02682 ↗
50. 10.1021/acs.analchem.0c0539010.1021/acs.analchem.0c05390 ↗
51. 10.1021/acsanm.0c0048110.1021/acsanm.0c00481 ↗
52. 10.1021/acsnano.1c0263010.1021/acsnano.1c02630 ↗
53. 10.1038/s41467-018-05103-w10.1038/s41467-018-05103-w ↗
54. 10.1021/acsnano.7b0792310.1021/acsnano.7b07923 ↗
55. 10.1021/jp203898r10.1021/jp203898r ↗
56. 10.1021/acsami.6b1043710.1021/acsami.6b10437 ↗
57. 10.1039/c0sm01229g10.1039/c0sm01229g ↗
58. 10.1021/jacs.7b1313610.1021/jacs.7b13136 ↗
59. 10.1038/nnano.2011.18910.1038/nnano.2011.189 ↗
60. 10.1021/ja312704e10.1021/ja312704e ↗
61. 10.1021/acs.accounts.8b0025510.1021/acs.accounts.8b00255 ↗
62. 10.1002/ejoc.20130007910.1002/ejoc.201300079 ↗
63. 10.1021/ja111418j10.1021/ja111418j ↗
64. 10.1021/cr500531510.1021/cr5005315 ↗
65. 10.1021/acsami.0c2305910.1021/acsami.0c23059 ↗
66. 10.1038/nature1073710.1038/nature10737 ↗
67. 10.1016/j.neuropharm.2010.08.02110.1016/j.neuropharm.2010.08.021 ↗
68. 10.1038/nn.214610.1038/nn.2146 ↗
69. 10.1074/jbc.M114.57152110.1074/jbc.M114.571521 ↗
70. 10.1038/nature1443110.1038/nature14431 ↗
71. 10.1021/acschemneuro.1c0074110.1021/acschemneuro.1c00741 ↗
72. 10.1021/ja808610410.1021/ja8086104 ↗
73. 10.1021/ja200493910.1021/ja2004939 ↗